Blog Post
June 23, 2022
Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
June 28, 2022
CGD has set up a working group to examine different ways to purchase antimicrobials in LMICs in order to identify actionable policies to improve access and stewardship for key products and increase funding for research into new ones. We are launching today the Working Group’s first working paper.
Blog Post
June 10, 2022
In June 2021, Dr. Tedros Ghebreyesus, offered a challenge to the world: “To truly end the pandemic, our goal must be to vaccinate at least 70 percent of the world’s population by the time you meet again in Germany next year.” However, as we approach this year’s G7 summit, the 70 percent target has b...
Blog Post
April 28, 2022
In the past two years, we have all learned that the end of a COVID-19 wave is the end of a chapter, not the end of the story. Ongoing COVID transmission means the risk of new variants of pandemic potential is ever present and vaccination remains our best defence. The primary near-term challenges for...
Blog Post
April 22, 2022
COVID-19 has reinforced the need for strong regulatory systems. The success of new technologies rapidly developed to mitigate the pandemic depends in no small part on key regulatory functions, such as oversight for clinical trials; review and authorization of medical products like vaccines, treatmen...
Blog Post
April 07, 2022
While oral antivirals are not a substitute for vaccination, they help prevent severe illness, save lives, and preserve health systems. Vaccination rates continue to lag in low-income countries: only 14 percent of the population in low-income countries has received one dose of the vaccine, compared t...
